Cipla to Market MSD's HIV Drug 'Raltegravir' in India

... Cipla Chief Medical Officer Jaideep Gogtay said the partnership reinforces the company's ongoing commitment to HIV/AIDS treatment, making life-saving drugs accessible. "Raltegravir, a third line therapy treatment will be a value addition to Cipla's ...

http://ift.tt/1dciX6O